COMP <GO>
NEUP vs JAGX // EV/EBITDA & P/E VALUATION
Neuphoria Therapeutics Inc. (NASDAQ) VS. Jaguar Health Inc. (NASDAQ) • 15-METRIC TALLY: NEUP 4
— JAGX 2
■ METRIC PARITY
LAST: $3.06 (-8.93%) • MKT CAP: $16.6M
valuation
—
LAST: $2.04 (-2.86%) • MKT CAP: $15.9M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEUP VS. JAGX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEUP | JAGX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.80% | -35.00% | +23.20 | NEUP | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.47% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -7.20% | -60.00% | +52.80 | NEUP | /operating-margins <GO> |
| Net Profit Margin | -2.40% | -0.50% | -1.90 | JAGX | /net-margins <GO> |
| Revenue Growth (YoY) | — | -1.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 1/9 | +4.00 | NEUP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 25.4 | 39.6 | -14.21 | JAGX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.6M | $15.9M | $642.4K | NEUP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEUP REV | JAGX REV | NEUP GROSS % | JAGX GROSS % | NEUP FCF | JAGX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $15.6M | $11.5M | — | 67.2% | $77.2K | -$23.7M |
| FY 2024 | $0 | $11.7M | — | 83.3% | -$14.7M | -$29.4M |
| FY 2023 | $0 | $9.8M | — | — | -$14.6M | -$33.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEUP // BETA —
JAGX // BETA —